| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LISATA THERAPEUTICS, INC. | SVP, Fin/Treas, Chief Actg Off | Common Stock | 23.5K | $87.6K | $3.73 | Jan 10, 2025 | Direct |
| LISATA THERAPEUTICS, INC. | SVP, Fin/Treas, Chief Actg Off | Stock Option (Right to Buy) | 7K | Jan 9, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| LSTA | LISATA THERAPEUTICS, INC. | Jan 9, 2025 | 6 | -$16.9K | 4 | Jan 13, 2025 | SVP, Fin/Treas, Chief Actg Off |
| LSTA | LISATA THERAPEUTICS, INC. | Oct 1, 2024 | 2 | $4.69K | 4 | Oct 2, 2024 | SVP, Fin/Treas, Chief Actg Off |
| LSTA | LISATA THERAPEUTICS, INC. | Apr 15, 2024 | 0 | $0 | 3 | Apr 24, 2024 | Senior Vice President, Finance and Treasury and Chief Accounting Officer Exhibit 24.1 - Power of Attorney |